TrialAnnals of oncology : official journal of the European Society for Medical Oncology2015

Utility of ¹⁸fluoro-deoxyglucose positron emission tomography for prognosis and response assessments in a phase 2 study of romidepsin in patients with relapsed or refractory peripheral T-cell lymphoma.

S Horwitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.